DILTIAZEM HYDROCHLORIDE | A219253 | ZYDUS LIFESCIENCES GLOBAL FZE
No patent or exclusivity listings for this strength.
Zydus Lifesciences' Diltiazem Hydrochloride NDA 219253 (supplement 003) changed from discontinued status to active prescription drug status.
Old: DISCN
New: RX
Zydus Lifesciences' diltiazem hydrochloride product (NDA 219253, supplement 003) received an AB therapeutic equivalence code, indicating bioequivalence to the reference product.
New: AB
Zydus Lifesciences' Diltiazem Hydrochloride (NDA 219253, supplement 002) transitioned from discontinued to active prescription drug status.
Old: DISCN
New: RX
Zydus Lifesciences' diltiazem hydrochloride NDA 219253 (supplement 002) received an AB therapeutic equivalence code, indicating bioequivalence to the reference product.
New: AB
Zydus Lifesciences' diltiazem hydrochloride application (NDA 219253, Supplement 004) status changed from discontinued to active prescription drug product.
Old: DISCN
New: RX
Zydus Lifesciences' diltiazem hydrochloride NDA 219253 transitioned from discontinued (DISCN) to active prescription (RX) status.
Old: DISCN
New: RX
Zydus Lifesciences' diltiazem hydrochloride (NDA 219253, Supplement 004) received a therapeutic equivalence rating of AB, indicating bioequivalence to the reference product.
New: AB
Zydus Lifesciences' Diltiazem Hydrochloride (NDA 219253) received therapeutic equivalence code AB, indicating bioequivalence to the reference product.
New: AB